Persistence of static lung hyperinflation in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor.
BACKGROUND This study sought to describe the prevalence of lung hyperinflation in adults (≥18 years) with cystic fibrosis (awCF) and the effects of elexacaftor-tezacaftor-ivacaftor (ETI) on hyperinflation. METHODS Consecutive awCF who initiated ETI at Cochin Hospital (Paris, France) and had performed body plethysmogr...